Application of a Mindfulness and Self-Compassion Program in Patients With Schizophrenia. Randomized Controlled Trial.
NCT ID: NCT04144075
Last Updated: 2019-11-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
150 participants
INTERVENTIONAL
2020-05-01
2021-02-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Compassion and Metacognition in Schizotypal Personality
NCT04764708
The Effect of a Mindfulness-Based Self-Compassion Program on Care Burden, Life Satisfaction, and Coping Levels of Caregivers of Individuals With Schizophrenia
NCT06941909
Mindfulness Meditation as a Rehabilitation Strategy for Persons With Schizophrenia
NCT00936351
Mindfulness-based Group Therapy for Inpatients With Schizophrenia Spectrum Disorders
NCT03671005
Efficacy of Mindfulness in PREventing Progression to Psychosis in Individuals With an Ultra High Risk for Psychosis
NCT06870305
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
DESIGN
Randomized clinical trial, three parallel groups:
1. Experimental, which will receive the MSC together with the usual treatment (TAU).
2. Active control, which will receive an alternative programme with cognitive, behavioural and psychoeducational components (CBTG) together with the TAU.
3. Passive control, which will receive the TAU. STUDY DISORDER
Schizophrenia. DATA FROM THE INTERVENTION UNDER STUDY Program developed by Kristin Neff and Christopher Germer, after observing in diverse investigations the inverse correlation between levels of self-pity and diverse pathological clinical variables.
POPULATION UNDER STUDY Patients from Telde's Mental Health Unit who have been diagnosed with schizophrenia.
TOTAL NUMBER OF SUBJECTS 150
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Mindful Self-Compassion
Protocolized training program in mindfulness and self-compassion skills.
Mindful Self-Compassion Program
It is a protocolized training program in mindfulness and self-compassion skills. It has a duration of 8 weekly group sessions of about two hours and 45 minutes and a silent retreat of 4 hours.
Cognitive Behaviour Therapy Group
A control intervention designed to develop a control group suitable for comparison with experimental groups receiving interventions based on mindfulness and compassion.
Cognitive Behaviour Therapy Group
It is a control intervention designed for the development of a control group suitable for comparison with experimental groups.
Treatment as Usual
Es variable según las características clínicas y personales del paciente.
Treatment as usual
It is variable according to the clinical and personal characteristics of the patient, the most common components will be described.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Mindful Self-Compassion Program
It is a protocolized training program in mindfulness and self-compassion skills. It has a duration of 8 weekly group sessions of about two hours and 45 minutes and a silent retreat of 4 hours.
Cognitive Behaviour Therapy Group
It is a control intervention designed for the development of a control group suitable for comparison with experimental groups.
Treatment as usual
It is variable according to the clinical and personal characteristics of the patient, the most common components will be described.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Gutiérrez-Hernández, ME
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gutiérrez-Hernández, ME
Psiquiatra Adjunto. Facultativo Especialista de Área.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alicia Díaz Megolla
Role: STUDY_DIRECTOR
Universidad de Las Palmas de Gran Canaria
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2019-434-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.